Breaking News

Charles River Launches pHelper Offering for AAV-based Gene Therapies

Designed to secure supply and streamline adeno-associated virus (AAV)-based gene therapy programs from early discovery through commercial manufacturing.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Charles River Laboratories International, Inc. has launched its off-the-shelf pHelper offering, which is designed to secure supply and streamline adeno-associated virus (AAV)-based gene therapy programs from early discovery through commercial manufacturing. It is available in Research Grade (RG), High Quality (HQ), and Good Manufacturing Practice (GMP)-grade.   Helper plasmids are the latest in a comprehensive collection of contract development and manufacturing organization (CDMO) products an...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters